Atlas FDA

Predicate Research Report · generated 2026-08-21 · Print / save as PDF · Save to account

MVM — Predicate Candidate Screening

40 FDA 510(k) clearances under this product code; the 50 most recent screened below.

125 daysmedian FDA review time
292 days90th percentile
40clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K200230Aptiva Celiac Disease IgG ReagentInova Diagnostics, Inc.2021-08-265740
K193604Aptiva Celiac Disease IgA ReagentInova Diagnostics, Inc.2021-06-165410
K181871EliA Celikey IgG Immunoassay; EliA GliadinDP IgA ImmunoassayPhadia AB2019-03-012320
K183313EUROIMMUN Anti-tissue Transglutaminase ELISA (IgA), EUROIMMUEuroimmun Us, Inc.2019-02-28910
K140691IG_PLEX CELIAC DGP PANELSqi Diagnostics Systems, Inc.2014-11-062320
K123713IMMULISA ENHANCED CELIAC FUSION (TTG/DGP) IGA/IGG ANTIBODY EImmco Diagnostics, Inc.2013-10-253250
K130053BIOPLEX 2200 CELIAC IGA AND IGG KITS ON THE BIOPLEX 2200 SYSBio-Rad Laboratories, Inc.2013-09-192470
K102490IGX PLEX CELIAC QUALITATIVE ASSAYSqi Diagnostics Systems2011-06-022750
K101644QUANTA FLASH H-TTG IGGInova Diagnostics, Inc.2011-03-232860
K102964EU-TTG IGA AND EU-TTG IGGGrifols USA, Inc.2011-03-071530
K094060QUANTA FLASH H-TTG IGAInova Diagnostics, Inc.2010-10-132860
K091520IMMULISA CELIAC TTG IGA AND IGG ANTIBODY ELISAImmco Diagnostics, Inc.2010-03-102920
K073145QUANTA LITE H-TTG SCREENInova Diagnostics, Inc.2008-02-12960
K072632QUANTA PLEX CELIAC IGG PROFILEInova Diagnostics, Inc.2008-02-111460
K072967QUANTA LITE F-ACTIN IGA ELISAInova Diagnostics, Inc.2008-01-28980
K071692THERATEST EL-TTG IGA/IGG AND THERATEST EL-GLIA IGA/IGG TEST Theratest Laboratories, Inc.2007-11-051380
K063818QUANTA PLEX CELIAC IGA PROFILEInova Diagnostics, Inc.2007-06-201800
K062787ELIA CELIKEY IGA WELL, MODEL 14-5517-01; ELIA CELIAC CONTROLPhadia US, Inc.2006-12-291020
K062583ELIA CELIKEY IGG WELL, MODEL 14-5518-01, ELIA CELIAC CONTROLPhadia US, Inc.2006-12-261160
K061408EUROIMMUN ENDOMYSIUM IFA: ESOPHAGUS (MONKEY) KITEuroimmun Us, LLC2006-10-051360
K060157IMMUGLO ANTI-ENDOMYSIAL ANTIBODY IFAImmco Diagnostics, Inc.2006-05-251250
K042644AESKULISA TTG A AND AESKULISA TTG GAesku, Inc.2005-06-012470
K043433AUTOSTAT II ANTI-TISSUE TRANSGLUTAMINASE IGG ELISAHycor Biomedical , Ltd.2005-03-07840
K041173CELIKEY IGG ITG IGG ANTIBODIES, MODEL 17996Sweden Diagnostics (Germany) GmbH2004-08-02890
K041174CELIKEY TTG (HUMAN, RECOMBINANT) IGA ANTIBODIES MODEL #18148Sweden Diagnostics (Germany) GmbH2004-07-19750
K040466BINDAZYME HUMAN ANTI TISSUE TRANSGLUTAMINASE IGA AND IGG EIAThe Binding Site2004-07-161440
K040095IMMULISA ANTI-HUMAN TISSUE TRANSGLUTAMINASE (HU-TTG) ANTIBODImmco Diagnostics, Inc.2004-03-05450
K033744AUTOSTAT II ANTI-TISUE TRANSGLUTAMINASE IGA ELISAHycor Biomedical , Ltd.2004-01-20500
K032571IMMULISA ANTI-HUMAN TISSUE TRANSGLUTAMINASE (HU-TTG) ANTIBODImmco Diagnostics, Inc.2003-12-241260
K011566QUANTA LITE H-TTG (HUMAN TISSUE TRANSGLUTAMINASE) IGA ELISAInova Diagnostics, Inc.2001-07-09490
K011570QUANTA LITE H-TTG (HUMAN TISSUE TRANSGLUTAMINASE) IGG ELISAInova Diagnostics, Inc.2001-07-09490
K010625EUROSPITAL EU-TTG IGA UMANAScimedx Corp.2001-04-24530
K002107IFA KIT FOR THE DETECTION OF ENDOMYSIAL IGA ANIBODIES USING Scimedx Corp.2000-08-04230
K994379EU-TTG IGA ELISAScimedx Corp.2000-02-18530
K993612BINDAZYME ANTI-TISSUE TRANSGLUTAMINASE IGA EIAThe Binding Site, Ltd.1999-12-21570
K993034MEDICA INDIRECT IMMUNOFLUORESCENCE (IIF) ANTI- ENDOMYSIAL ANMedica, Inc.1999-11-01530
K992878ANTI-TISSUE TRANSGLUTAMINASE (TTG)ANTIBODY TESTImmco Diagnostics, Inc.1999-10-15500
K984137QUANTA LITE CELIAC SCREEN (TISSUE TRANSGLUTAMINASE/GLIADIN) Inova Diagnostics, Inc.1999-01-28710
K981209MONKEY OESOPHAGUS IFA DIAGNOSTIC TEST KITSThe Binding Site, Ltd.1998-10-222030
K982366QUANTA LITE TTG (TISSUE TRANSGLUTAMINASE) ELISAInova Diagnostics, Inc.1998-08-27510

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda